Drug-price reforms need not affect research on rare diseases – or the Canadians who have them
On Aug. 9, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for new patented medicines that will go into effect in 2020. And that has raised worries among tho…
